Oralair®: sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis

2011 ◽  
Vol 7 (4) ◽  
pp. 437-444 ◽  
Author(s):  
Jison Hong ◽  
Leonard Bielory
Keyword(s):  
Grass Pollen ◽  
Sublingual Immunotherapy ◽  
Allergic Rhinoconjunctivitis

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis

2009 ◽  
Vol 123 (1) ◽  
pp. 160-166.e3 ◽  
Author(s):  
Ulrich Wahn ◽  
Ana Tabar ◽  
Piotr Kuna ◽  
Susanne Halken ◽  
Armelle Montagut ◽  
...  
Keyword(s):  
Grass Pollen ◽  
Sublingual Immunotherapy ◽  
Allergic Rhinoconjunctivitis ◽  
Efficacy And Safety

scholarly journals EXPERIENCE WITH THE CARBAMYLATED MONOMERIC ALLERGOID LAIS ® FOR SUBLINGUAL IMMUNOTHERAPY IN PATIENTS WITH GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS

2013 ◽  
Vol 10 (6) ◽  
pp. 58-63
Author(s):  
I V Danilycheva ◽  
N I Ilina ◽  
A E Shulzhenko
Keyword(s):  
Grass Pollen ◽  
Sublingual Immunotherapy ◽  
Allergic Rhinoconjunctivitis ◽  
Noncomparative Study

The article presents the results of a prospective noncomparative study of use of carbamylated monomeric allergoid Lais ® for sublingual immunotherapy (SLIT) in patients with allergic rhinoconjunctivitis caused by pollen grasses. We suggest that SLIT with Lais ® sublingual tablets is an effective and welltolerated form of treatment.

scholarly journals Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis

2015 ◽  
Vol 175 (8) ◽  
pp. 1301 ◽  
Author(s):  
Danilo Di Bona ◽  
Antonella Plaia ◽  
Maria Stefania Leto-Barone ◽  
Simona La Piana ◽  
Gabriele Di Lorenzo
Keyword(s):  
Grass Pollen ◽  
Sublingual Immunotherapy ◽  
Allergic Rhinoconjunctivitis ◽  
Pollen Allergen ◽  
Grass Pollen Allergen

scholarly journals Experience with the carbamylated monomeric allergoid Lais® for sublingual immunotherapy in patients with grass pollen or mite-induced allergic rhinoconjunctivitis

2015 ◽  
Vol 12 (1) ◽  
pp. 60-64
Author(s):  
I V Danilycheva ◽  
N I Ilina ◽  
A E Shulzhenko
Keyword(s):  
Grass Pollen ◽  
Sublingual Immunotherapy ◽  
Allergic Rhinoconjunctivitis ◽  
Noncomparative Study

The article presents the results of a prospective noncomparative study of carbamylated monomeric allergoid Lais ® for sublingual immunotherapy (SLIT) in patients with allergic rhinoconjunctivitis caused by pollen grasses. We suggest that SLIT using Lais ® sublingual tablets is an effective and well-tolerated method of treatment.

Sign in / Sign up

Export Citation Format

Share Document